Charlie is a Partner and patent litigator at Marks & Clerk Law who advises clients on the enforcement, defence and commercialisation of intellectual property, with a particular focus on patent and licensing disputes in the life sciences field. In addition to biopharmaceutical patent litigation, Charlie’s expertise extends to litigation, arbitration and commercial IP matters in fields ranging from medical devices, manufacturing and oil and gas to electronics, telecommunications and technology.
Charlie is well accustomed to handling multijurisdictional matters involving teams from across the world, often coordinating global and European litigation strategies for his clients and advising on the interaction between parallel litigation and EPO opposition proceedings. He also advises clients on related regulatory data protection and SPC matters. Recent and ongoing work includes advice for global biopharmaceutical clients on patent enforcement strategies concerning products in the oncology, autoimmune and pain fields.
In addition to his litigation practice, Charlie also advises clients on freedom to operate and IP due diligence, assisting clients with strategic investment decisions where IP is concerned.
After playing a leading role in a number of complex and high profile disputes and with 20 years’ experience in IP, Charlie is recognised as a global leader in life sciences patent litigation.
Charlie is recognised as a Recommended Lawyer in the Legal 500 (2023), IAM Patent 1000 (2023) and as a Global Leader for Life Sciences Patent Litigation and Patents in Who’s Who Legal (2023).
Charlie became a partner in 2014.